Ani Pharmaceuticals (ANIP) Change in Cash (2010 - 2026)

Ani Pharmaceuticals has disclosed Change in Cash across 17 years of filings, most recently posting $49.0 million for Q2 2026.

• In Q2 2026, Change in Cash fell 27.89% year-over-year to $49.0 million; the TTM figure through Jun 2026 stood at $142.4 million (up 739.29% YoY), while the FY2025 annual figure was $140.7 million, up 284.62% from the prior year.
• Change in Cash came in at $49.0 million for Q2 2026 at Ani Pharmaceuticals, up from $25.6 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $94.0 million in Q2 2023 to a low of -$95.1 million in Q3 2024.
• Average Change in Cash over 5 years is $14.2 million, with a median of $13.0 million recorded in 2023.
• Year-over-year, Change in Cash tumbled 1567.69% in 2022 and soared 18778.86% in 2025.
• Over 5 years, Change in Cash stood at -$8.0 million in 2022, then surged by 448.36% to $28.0 million in 2023, then plunged by 100.44% to -$123000.0 in 2024, then soared by 18778.86% to $23.0 million in 2025, then surged by 113.43% to $49.0 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were $49.0 million in Q2 2026, $25.6 million in Q1 2026, and $23.0 million in Q4 2025.